IMC:ASX
Immuron Ltd
၀.၀၃၇ A$
၀.၀၀%
(၀.၀၀) 1D
နို ၂၀, GMT+၁၁ ၁၅:၀၁:၀၆ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IMC...
Open
၀.၀၄ A$
High
၀.၀၄ A$
Low
၀.၀၄ A$
Mkt. cap
၁.၁၀ ကုဋေ
Avg. vol.
၁.၃၄ သိန်း
Volume
၉.၈၅ သိန်း
52-wk high
၀.၀၇ A$
52-wk low
၀.၀၃ A$
EPS
-၀.၀၁ A$
Shares outstanding
၃၂.၂၈ ကုဋေ
No. of employees
၈
Open
၀.၀၄ A$
High
၀.၀၄ A$
Low
၀.၀၄ A$
Mkt. cap
၁.၁၀ ကုဋေ
Avg. vol.
၁.၃၄ သိန်း
Volume
၉.၈၅ သိန်း
52-wk high
၀.၀၇ A$
52-wk low
၀.၀၃ A$
EPS
-၀.၀၁ A$
Shares outstanding
၃၂.၂၈ ကုဋေ
No. of employees
၈
News stories
From web sources and news partners
Benzinga
·
ပြီးခဲ့သည့် ၁၃ မိနစ်
Stock Market: Will S&P 500 Open Up or Down Today?
FOREX.com
·
ပြီးခဲ့သည့် ၄၈ မိနစ်
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
Adam Feldman | Substack
·
ပြီးခဲ့သည့် ၁၂ နာရီ
Inside the Federal Litigation of Five S&P 500 Giants
BigGo Finance
·
ပြီးခဲ့သည့် ၅ နာရီ
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
Profile
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
About Immuron Ltd
CEO-
Employees၈
Founded၁၉၉၄
HeadquartersBlackburn North, ဝိတိုရိယ ပြည်နယ်, ဩစတြေးလျ
SectorHealth Care
Industry-
Websiteimmuron.com.au